
We welcome you to submit challenging cases from your genetic cancer risk assessment practice for consideration to be presented at our conference. If selected, you will receive expert feedback from our esteemed faculty during the Case Presentation Workshops. We are particularly interested in cases that touch on the following topics and issues:
- Case Session 1 - Somatic & Germline Testing
- Tumor/Germline genomic testing
- Somatic sequencing with implications for germline testing
- Recognizing genetic and genomic indicators for targeted treatment
- Case Session 2 - HBOC, Moderate Risk, & Risk Management
- Moderate risk genes
- Li-Fraumeni Syndrome
- Breast screening & management
- Case Session 3 - GI, Inequities, & Targeted Therapies
- Lynch/Lynch-like
- LGBTQ+ patient populations
- Treatment implications from test results
For any further inquiries, contact [email protected].
Important Dates & Deadlines
January 2023 |
Call for Cases |
March 17th, 2023 |
Case Submission Deadline |
March 17th to March 31st, 2023 |
Case Review Process |
April 1st, 2023 |
Case Acceptance/Rejection notices emailed |
April 7th, 2023 |
Case Withdrawal Deadline |
May 5th to May 7th, 2023 |
See you in Universal City, California! |